Christopher Hulton, PhD

Research Scientist at C4 Therapeutic, Watertown, Massachusetts

Christopher Hulton, PhD

Research Scientist at C4 Therapeutic, Watertown, Massachusetts

Share
Print
Share
Print
Pictured: Christopher Hulton

Dissertation

Direct Genome Editing of Patient-Derived Xenografts Using CRISPR-Cas9 Enables Rapid in vivo Functional Genomics (2019)

Mentor

Charles M. Rudin

End Year

2019

Education

BS, Northeastern University

Current Title & Affiliations

Research Scientist, C4 Theraputics Inc.

Publications

Hulton, C.H., Costa, E.A., Shah, N.S. et al. Direct genome editing of patient-derived xenografts using CRISPR-Cas9 enables rapid in vivo functional genomics. (2020) Nat Cancer 1, 359–369 (2020). doi.org/10.1038/s43018-020-0040-8